IBDEI0DR ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18402,1,3,0)
 ;;=3^424.1
 ;;^UTILITY(U,$J,358.3,18402,1,4,0)
 ;;=4^AORTIC VALVE DIS
 ;;^UTILITY(U,$J,358.3,18402,2)
 ;;=^9330
 ;;^UTILITY(U,$J,358.3,18403,0)
 ;;=459.81^^114^1070^14
 ;;^UTILITY(U,$J,358.3,18403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18403,1,3,0)
 ;;=3^459.81
 ;;^UTILITY(U,$J,358.3,18403,1,4,0)
 ;;=4^VENOUS INSUFFICIENCY
 ;;^UTILITY(U,$J,358.3,18403,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,18404,0)
 ;;=411.1^^114^1070^2
 ;;^UTILITY(U,$J,358.3,18404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18404,1,3,0)
 ;;=3^411.1
 ;;^UTILITY(U,$J,358.3,18404,1,4,0)
 ;;=4^ANGINA PECTORIS/UNSTABLE
 ;;^UTILITY(U,$J,358.3,18404,2)
 ;;=^7455
 ;;^UTILITY(U,$J,358.3,18405,0)
 ;;=429.2^^114^1070^4
 ;;^UTILITY(U,$J,358.3,18405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18405,1,3,0)
 ;;=3^429.2
 ;;^UTILITY(U,$J,358.3,18405,1,4,0)
 ;;=4^ASCVD
 ;;^UTILITY(U,$J,358.3,18405,2)
 ;;=^19738
 ;;^UTILITY(U,$J,358.3,18406,0)
 ;;=414.01^^114^1070^6
 ;;^UTILITY(U,$J,358.3,18406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18406,1,3,0)
 ;;=3^414.01
 ;;^UTILITY(U,$J,358.3,18406,1,4,0)
 ;;=4^CAD
 ;;^UTILITY(U,$J,358.3,18406,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,18407,0)
 ;;=401.9^^114^1070^9
 ;;^UTILITY(U,$J,358.3,18407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18407,1,3,0)
 ;;=3^401.9
 ;;^UTILITY(U,$J,358.3,18407,1,4,0)
 ;;=4^HYPERTENSION, ESSENTIAL
 ;;^UTILITY(U,$J,358.3,18407,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,18408,0)
 ;;=394.0^^114^1070^11
 ;;^UTILITY(U,$J,358.3,18408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18408,1,3,0)
 ;;=3^394.0
 ;;^UTILITY(U,$J,358.3,18408,1,4,0)
 ;;=4^MITRAL STENOSIS
 ;;^UTILITY(U,$J,358.3,18408,2)
 ;;=^78404
 ;;^UTILITY(U,$J,358.3,18409,0)
 ;;=285.9^^114^1071^1
 ;;^UTILITY(U,$J,358.3,18409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18409,1,3,0)
 ;;=3^285.9
 ;;^UTILITY(U,$J,358.3,18409,1,4,0)
 ;;=4^ANEMIA
 ;;^UTILITY(U,$J,358.3,18409,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,18410,0)
 ;;=266.2^^114^1071^2
 ;;^UTILITY(U,$J,358.3,18410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18410,1,3,0)
 ;;=3^266.2
 ;;^UTILITY(U,$J,358.3,18410,1,4,0)
 ;;=4^B12 & FOLATE ANEMIA
 ;;^UTILITY(U,$J,358.3,18410,2)
 ;;=^87347
 ;;^UTILITY(U,$J,358.3,18411,0)
 ;;=272.0^^114^1071^3
 ;;^UTILITY(U,$J,358.3,18411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18411,1,3,0)
 ;;=3^272.0
 ;;^UTILITY(U,$J,358.3,18411,1,4,0)
 ;;=4^CHOLESTEROL (HYPER)
 ;;^UTILITY(U,$J,358.3,18411,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,18412,0)
 ;;=250.00^^114^1071^6
 ;;^UTILITY(U,$J,358.3,18412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18412,1,3,0)
 ;;=3^250.00
 ;;^UTILITY(U,$J,358.3,18412,1,4,0)
 ;;=4^DIABETES MEL W/O COMP, TYPE II
 ;;^UTILITY(U,$J,358.3,18412,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,18413,0)
 ;;=250.02^^114^1071^5
 ;;^UTILITY(U,$J,358.3,18413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18413,1,3,0)
 ;;=3^250.02
 ;;^UTILITY(U,$J,358.3,18413,1,4,0)
 ;;=4^DIAB MEL W/O COMP, TYPE II UNCONT
 ;;^UTILITY(U,$J,358.3,18413,2)
 ;;=^295704
 ;;^UTILITY(U,$J,358.3,18414,0)
 ;;=272.4^^114^1071^9
 ;;^UTILITY(U,$J,358.3,18414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18414,1,3,0)
 ;;=3^272.4
 ;;^UTILITY(U,$J,358.3,18414,1,4,0)
 ;;=4^HYPERLIPIDEMIA
 ;;^UTILITY(U,$J,358.3,18414,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,18415,0)
 ;;=244.9^^114^1071^10
 ;;^UTILITY(U,$J,358.3,18415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18415,1,3,0)
 ;;=3^244.9
 ;;^UTILITY(U,$J,358.3,18415,1,4,0)
 ;;=4^HYPOTHYROIDISM
 ;;^UTILITY(U,$J,358.3,18415,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,18416,0)
 ;;=250.01^^114^1071^4
 ;;^UTILITY(U,$J,358.3,18416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18416,1,3,0)
 ;;=3^250.01
 ;;^UTILITY(U,$J,358.3,18416,1,4,0)
 ;;=4^DIAB MEL W/O COMP, TYPE I
 ;;^UTILITY(U,$J,358.3,18416,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,18417,0)
 ;;=278.01^^114^1071^11
 ;;^UTILITY(U,$J,358.3,18417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18417,1,3,0)
 ;;=3^278.01
 ;;^UTILITY(U,$J,358.3,18417,1,4,0)
 ;;=4^OBESITY, MORBID
 ;;^UTILITY(U,$J,358.3,18417,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,18418,0)
 ;;=286.59^^114^1071^7
 ;;^UTILITY(U,$J,358.3,18418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18418,1,3,0)
 ;;=3^286.59
 ;;^UTILITY(U,$J,358.3,18418,1,4,0)
 ;;=4^HEMOR D/O DUE TO CIRC ANTICOAG
 ;;^UTILITY(U,$J,358.3,18418,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,18419,0)
 ;;=268.9^^114^1071^12
 ;;^UTILITY(U,$J,358.3,18419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18419,1,3,0)
 ;;=3^268.9
 ;;^UTILITY(U,$J,358.3,18419,1,4,0)
 ;;=4^VITAMIN D DEFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,18419,2)
 ;;=^126968
 ;;^UTILITY(U,$J,358.3,18420,0)
 ;;=790.29^^114^1071^8
 ;;^UTILITY(U,$J,358.3,18420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18420,1,3,0)
 ;;=3^790.29
 ;;^UTILITY(U,$J,358.3,18420,1,4,0)
 ;;=4^HYPERGLYCEMIA
 ;;^UTILITY(U,$J,358.3,18420,2)
 ;;=^329955
 ;;^UTILITY(U,$J,358.3,18421,0)
 ;;=389.9^^114^1072^7
 ;;^UTILITY(U,$J,358.3,18421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18421,1,3,0)
 ;;=3^389.9
 ;;^UTILITY(U,$J,358.3,18421,1,4,0)
 ;;=4^HEARING LOSS
 ;;^UTILITY(U,$J,358.3,18421,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,18422,0)
 ;;=380.4^^114^1072^8
 ;;^UTILITY(U,$J,358.3,18422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18422,1,3,0)
 ;;=3^380.4
 ;;^UTILITY(U,$J,358.3,18422,1,4,0)
 ;;=4^IMPACTED CERUMEN
 ;;^UTILITY(U,$J,358.3,18422,2)
 ;;=^62061
 ;;^UTILITY(U,$J,358.3,18423,0)
 ;;=382.9^^114^1072^9
 ;;^UTILITY(U,$J,358.3,18423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18423,1,3,0)
 ;;=3^382.9
 ;;^UTILITY(U,$J,358.3,18423,1,4,0)
 ;;=4^OTITIS MEDIA
 ;;^UTILITY(U,$J,358.3,18423,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,18424,0)
 ;;=365.11^^114^1072^5
 ;;^UTILITY(U,$J,358.3,18424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18424,1,3,0)
 ;;=3^365.11
 ;;^UTILITY(U,$J,358.3,18424,1,4,0)
 ;;=4^GLAUCOMA,PRIMARY OPEN ANGLE
 ;;^UTILITY(U,$J,358.3,18424,2)
 ;;=^51203
 ;;^UTILITY(U,$J,358.3,18425,0)
 ;;=372.72^^114^1072^10
 ;;^UTILITY(U,$J,358.3,18425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18425,1,3,0)
 ;;=3^372.72
 ;;^UTILITY(U,$J,358.3,18425,1,4,0)
 ;;=4^SUBCONJUNCTIVAL HEMORRHAGE
 ;;^UTILITY(U,$J,358.3,18425,2)
 ;;=^27538
 ;;^UTILITY(U,$J,358.3,18426,0)
 ;;=365.70^^114^1072^1
 ;;^UTILITY(U,$J,358.3,18426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18426,1,3,0)
 ;;=3^365.70
 ;;^UTILITY(U,$J,358.3,18426,1,4,0)
 ;;=4^GLAUCOMA STAGE NOS
 ;;^UTILITY(U,$J,358.3,18426,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,18427,0)
 ;;=365.71^^114^1072^3
 ;;^UTILITY(U,$J,358.3,18427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18427,1,3,0)
 ;;=3^365.71
 ;;^UTILITY(U,$J,358.3,18427,1,4,0)
 ;;=4^GLAUCOMA,MILD STAGE
 ;;^UTILITY(U,$J,358.3,18427,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,18428,0)
 ;;=365.72^^114^1072^4
 ;;^UTILITY(U,$J,358.3,18428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18428,1,3,0)
 ;;=3^365.72
 ;;^UTILITY(U,$J,358.3,18428,1,4,0)
 ;;=4^GLAUCOMA,MODERATE STAGE
 ;;^UTILITY(U,$J,358.3,18428,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,18429,0)
 ;;=365.73^^114^1072^6
 ;;^UTILITY(U,$J,358.3,18429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18429,1,3,0)
 ;;=3^365.73
 ;;^UTILITY(U,$J,358.3,18429,1,4,0)
 ;;=4^GLAUCOMA,SEVERE STAGE
 ;;^UTILITY(U,$J,358.3,18429,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,18430,0)
 ;;=365.74^^114^1072^2
 ;;^UTILITY(U,$J,358.3,18430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18430,1,3,0)
 ;;=3^365.74
 ;;^UTILITY(U,$J,358.3,18430,1,4,0)
 ;;=4^GLAUCOMA,INDETERM STAGE
 ;;^UTILITY(U,$J,358.3,18430,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,18431,0)
 ;;=571.5^^114^1073^1
 ;;^UTILITY(U,$J,358.3,18431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18431,1,3,0)
 ;;=3^571.5
 ;;^UTILITY(U,$J,358.3,18431,1,4,0)
 ;;=4^CIRRHOSIS OF LIVER
 ;;^UTILITY(U,$J,358.3,18431,2)
 ;;=^24731
 ;;^UTILITY(U,$J,358.3,18432,0)
 ;;=530.81^^114^1073^2
 ;;^UTILITY(U,$J,358.3,18432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18432,1,3,0)
 ;;=3^530.81
 ;;^UTILITY(U,$J,358.3,18432,1,4,0)
 ;;=4^ESOPHAGEAL REFLUX (GERD)
 ;;^UTILITY(U,$J,358.3,18432,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,18433,0)
 ;;=558.9^^114^1073^4
 ;;^UTILITY(U,$J,358.3,18433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18433,1,3,0)
 ;;=3^558.9
 ;;^UTILITY(U,$J,358.3,18433,1,4,0)
 ;;=4^GASTROENTERITIS/COLITIS, NONINFECT
 ;;^UTILITY(U,$J,358.3,18433,2)
 ;;=^87311
 ;;^UTILITY(U,$J,358.3,18434,0)
 ;;=564.1^^114^1073^8
 ;;^UTILITY(U,$J,358.3,18434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18434,1,3,0)
 ;;=3^564.1
 ;;^UTILITY(U,$J,358.3,18434,1,4,0)
 ;;=4^IRRITABLE COLON
 ;;^UTILITY(U,$J,358.3,18434,2)
 ;;=^65682
 ;;^UTILITY(U,$J,358.3,18435,0)
 ;;=211.3^^114^1073^9
 ;;^UTILITY(U,$J,358.3,18435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18435,1,3,0)
 ;;=3^211.3
 ;;^UTILITY(U,$J,358.3,18435,1,4,0)
 ;;=4^POLYPS, COLON/LG BOWEL (BENIGN NEO
 ;;^UTILITY(U,$J,358.3,18435,2)
 ;;=^13295
 ;;^UTILITY(U,$J,358.3,18436,0)
 ;;=533.90^^114^1073^10
 ;;^UTILITY(U,$J,358.3,18436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18436,1,3,0)
 ;;=3^533.90
 ;;^UTILITY(U,$J,358.3,18436,1,4,0)
 ;;=4^ULCER, PEPTIC
 ;;^UTILITY(U,$J,358.3,18436,2)
 ;;=^93051
 ;;^UTILITY(U,$J,358.3,18437,0)
 ;;=535.00^^114^1073^3
 ;;^UTILITY(U,$J,358.3,18437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18437,1,3,0)
 ;;=3^535.00
 ;;^UTILITY(U,$J,358.3,18437,1,4,0)
 ;;=4^GASTRITIS, ACUTE
 ;;^UTILITY(U,$J,358.3,18437,2)
 ;;=^270169
 ;;^UTILITY(U,$J,358.3,18438,0)
 ;;=070.54^^114^1073^6
 ;;^UTILITY(U,$J,358.3,18438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18438,1,3,0)
 ;;=3^070.54
 ;;^UTILITY(U,$J,358.3,18438,1,4,0)
 ;;=4^HEPATITIS C,CHRONIC,W/O COMA
 ;;^UTILITY(U,$J,358.3,18438,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,18439,0)
 ;;=553.9^^114^1073^7
 ;;^UTILITY(U,$J,358.3,18439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18439,1,3,0)
 ;;=3^553.9
 ;;^UTILITY(U,$J,358.3,18439,1,4,0)
 ;;=4^HERNIA
